1. Home
  2. PRPO vs LMFA Comparison

PRPO vs LMFA Comparison

Compare PRPO & LMFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • LMFA
  • Stock Information
  • Founded
  • PRPO N/A
  • LMFA 2008
  • Country
  • PRPO United States
  • LMFA United States
  • Employees
  • PRPO N/A
  • LMFA N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • LMFA Finance: Consumer Services
  • Sector
  • PRPO Industrials
  • LMFA Finance
  • Exchange
  • PRPO Nasdaq
  • LMFA Nasdaq
  • Market Cap
  • PRPO 8.8M
  • LMFA 9.2M
  • IPO Year
  • PRPO N/A
  • LMFA 2015
  • Fundamental
  • Price
  • PRPO $5.79
  • LMFA $2.28
  • Analyst Decision
  • PRPO
  • LMFA Hold
  • Analyst Count
  • PRPO 0
  • LMFA 1
  • Target Price
  • PRPO N/A
  • LMFA N/A
  • AVG Volume (30 Days)
  • PRPO 5.7K
  • LMFA 149.6K
  • Earning Date
  • PRPO 11-06-2024
  • LMFA 11-13-2024
  • Dividend Yield
  • PRPO N/A
  • LMFA N/A
  • EPS Growth
  • PRPO N/A
  • LMFA N/A
  • EPS
  • PRPO N/A
  • LMFA N/A
  • Revenue
  • PRPO $17,411,000.00
  • LMFA $12,838,084.00
  • Revenue This Year
  • PRPO $75.18
  • LMFA N/A
  • Revenue Next Year
  • PRPO N/A
  • LMFA N/A
  • P/E Ratio
  • PRPO N/A
  • LMFA N/A
  • Revenue Growth
  • PRPO 31.31
  • LMFA 27.81
  • 52 Week Low
  • PRPO $4.31
  • LMFA $2.18
  • 52 Week High
  • PRPO $7.30
  • LMFA $6.11
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 41.19
  • LMFA 34.52
  • Support Level
  • PRPO $5.72
  • LMFA $2.67
  • Resistance Level
  • PRPO $6.48
  • LMFA $2.90
  • Average True Range (ATR)
  • PRPO 0.24
  • LMFA 0.25
  • MACD
  • PRPO 0.01
  • LMFA -0.06
  • Stochastic Oscillator
  • PRPO 0.00
  • LMFA 8.49

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About LMFA LM Funding America Inc.

LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.

Share on Social Networks: